FYERS
Home
/
Stocks
/
Profit Loss
/
Acutaas Chemicals Profit & Loss

Acutaas Chemicals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020
₹330 Cr₹433 Cr₹393 Cr₹306 Cr₹207 Cr₹308 Cr₹275 Cr₹247 Cr₹177 Cr₹225 Cr₹166 Cr₹172 Cr₹142 Cr₹186 Cr₹152 Cr₹147 Cr₹131 Cr₹144 Cr₹141 Cr₹122 Cr₹113 Cr₹93 Cr₹92 Cr₹91 Cr
₹2 Cr₹11 Cr₹5 Cr₹10 Cr₹16 Cr₹6 Cr₹2 Cr₹8 Cr₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹1 Cr-₹17 L₹3 Cr₹85 L₹62 L₹18 L₹1 Cr₹16 L₹1 Cr₹20,000₹17 L₹1 Cr
₹331 Cr₹444 Cr₹398 Cr₹316 Cr₹223 Cr₹314 Cr₹277 Cr₹255 Cr₹178 Cr₹226 Cr₹170 Cr₹174 Cr₹143 Cr₹186 Cr₹155 Cr₹148 Cr₹132 Cr₹144 Cr₹143 Cr₹122 Cr₹114 Cr₹93 Cr₹92 Cr₹92 Cr
₹226 Cr₹259 Cr₹252 Cr₹219 Cr₹164 Cr₹231 Cr₹213 Cr₹205 Cr₹153 Cr₹187 Cr₹144 Cr₹151 Cr₹121 Cr₹149 Cr₹125 Cr₹122 Cr₹111 Cr₹121 Cr₹114 Cr₹97 Cr₹93 Cr₹71 Cr₹71 Cr₹71 Cr
₹115 Cr₹195 Cr₹155 Cr₹105 Cr₹67 Cr₹91 Cr₹70 Cr₹57 Cr₹31 Cr₹45 Cr₹30 Cr₹26 Cr₹26 Cr₹41 Cr₹34 Cr₹29 Cr₹24 Cr₹26 Cr₹31 Cr₹28 Cr₹23 Cr₹23 Cr₹22 Cr₹23 Cr
₹1 Cr₹1 Cr₹86 L₹58 L₹64 L₹60 L₹69 L₹50 L₹4 Cr₹2 Cr₹3 Cr₹82 L₹51 L₹59 L₹1 Cr₹45 L₹18 L₹59 L₹34 L₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr
₹104 Cr₹184 Cr₹145 Cr₹96 Cr₹58 Cr₹83 Cr₹63 Cr₹50 Cr₹20 Cr₹37 Cr₹24 Cr-₹10 Cr₹22 Cr₹37 Cr₹30 Cr₹26 Cr₹20 Cr₹22 Cr₹29 Cr₹23 Cr₹18 Cr₹21 Cr₹19 Cr₹20 Cr
₹75 Cr₹134 Cr₹106 Cr₹72 Cr₹44 Cr₹63 Cr₹45 Cr₹38 Cr₹15 Cr₹26 Cr₹18 Cr-₹17 Cr₹17 Cr₹27 Cr₹22 Cr₹19 Cr₹15 Cr₹21 Cr₹19 Cr₹17 Cr₹14 Cr₹15 Cr₹14 Cr₹15 Cr

Share Price Live Stats

Open (₹)3,211.10
Volume (₹)87,702.00
High (₹)3,228.80
Upper Circuit3,841.20
Low (₹)3,162.00
Lower Circuit2,560.80
Prev Close3,201.00
52W High (₹)3,740.00
Price3,196.10
52W Low (₹)1,302.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)26194.30 Cr
Div. Yield (%)0.08
PE Ratio67.82
Debt to Equity0.02
Price to Book12.69
Book Value201.59
EPS (TTM)47.17
Face Value5.00
ROE (%)24.08

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ACUTAASNSE
LTP
1W Low
1W High
Market cap (₹)
1901.2-18.8 (-0.98%)
1900.10
1984.80
4,56,833Cr
9187.5-51.5 (-0.56%)
9087
9467
2,45,426Cr
4860-190 (-3.76%)
4854
5066
1,87,320Cr
1132.3-58.7 (-4.93%)
1125.10
1187
1,13,217Cr
1380.2-43.3 (-3.04%)
1376.70
1426.10
1,12,212Cr
1851.3-87.2 (-4.50%)
1811.70
1949
1,01,155Cr
2122.5-49 (-2.26%)
2118.10
2192
97,626Cr
2337.4-45.5 (-1.91%)
2335
2419.20
96,859Cr
1161.8-16.2 (-1.38%)
1154.40
1179.90
96,406Cr
1656.7+11.4 (0.69%)
1622.60
1717
93,614Cr
3196.1-85.5 (-2.61%)
3120
3321.90
26,194Cr

Key Highlights of Acutaas Chemicals Ltd’s P&L

In 2026-03-31, Acutaas Chemicals Ltd reported total revenue of ₹1380.96Cr, compared with ₹1023.81Cr in 2025-03-31, reflecting Acutaas Chemicals Ltd turnover.

Depreciation was ₹35.99Cr and finance costs were ₹3.27Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹482.73Cr in 2026-03-31 as compared to ₹216.16Cr in 2025-03-31.

Net Profit (PAT) was ₹356.25Cr in 2026-03-31 compared with ₹158.71Cr in 2025-03-31.

Earnings per share (EPS) were ₹43.51 in 2026-03-31, compared with ₹19.39 in 2025-03-31.